News FDA approves consumer colorectal cancer test The FDA will allow consumer DNA testing company 23andMe to give customers reports on their risk of hereditary colorectal cancer.
News FDA approval for 23andMe's direct-to-consumer genetics test Service can now be marketed as test for Alheimer's and Parkinson's, among others.
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.